1. Nurses' Toolbox: How to Improve Patient Outcomes in Multiple Myeloma

3. Program Goals

4. Defining Multiple Myeloma

5. Case 1

6. Diagnostic Criteria Multiple Myeloma Requiring Therapy

9. Cytogenetic Risk Features

10. Case 1 (cont)

11. Newly Diagnosed Multiple Myeloma NCCN® Therapy for Transplant-Eligible Patients

12. FIRST Trial

13. SWOG S0777 Trial

14. Therapy Modifications With PN

15. Peripheral Neuropathy in Multiple Myeloma

16. Nursing Care for Peripheral Neuropathy

17. Nursing Care for Peripheral Neuropathy (cont)

18. Therapy Classes for MM

21. Bisphosphonates in MM IMWG Recommendations

22. Maintenance Therapy

25. Patient Case 1 (cont)

27. Multiple Myeloma Therapy for Previously Treated Disease

28. Shared Decision Making

29. Considerations for This Patient

30. Ixazomib/Lenalidomide/ Dexamethasone Therapy

31. Strategies to Aid Patient Compliance

32. ELOQUENT-2 Len/Dex ± Elotuzumab

33. Elotuzumab

34. Therapy and Diagnostic Testing

35. Carfilzomib: Clinical Trials

36. Carfilzomib

37. Patient Case 1 Combinations With Len/Dex at Early Relapse

38. Daratumumab Anti-CD38 Antibody

39. Daratumumab

40. Managing Infections

41. Pomalidomide

42. Panobinostat

43. Survivorship Plans

44. Survivorship Plans (cont)

45. Concluding Remarks

46. Concluding Remarks (cont)

47. Abbreviations

48. Abbreviations (cont)

49. Abbreviations (cont)